Moderate hyperhomocysteinemia in patients with Huntington's disease

Pteridines

Volumn 13, Issue 4, 2002, Pages 121-125

  Laich, Andreas ^a   Leblhuber, Friedrich ^b   Widner, Bernhard ^a   Frick, Barbara ^a   Jellinger, Kurt ^c   Fuchs, Dietmar ^a,c  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Dementia; Homocysteine; Huntington's disease; Neopterin

Indexed keywords

CLONAZEPAM; FOLIC ACID; HALOPERIDOL; HOMOCYSTEINE; NEOPTERIN;

ADULT; AGE DISTRIBUTION; AGING; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUNTINGTON CHOREA; HYPERHOMOCYSTEINEMIA; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SERUM; VITAMIN BLOOD LEVEL;

EID: 0036988743     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.2002.13.4.121     Document Type: Article

References (30)

1. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995, 274:1049-1057
2. Boutell JM, Wood JD, Harper PS, Jones AL: Huntingtin interacts with cystathionine beta-synthase. Hum Mol Genet 1998, 7:371-378
3. Clarke R, Smith AD, Jobst KA, Refsum H, Surtton L, Ueland PM: Folate, vitamin B12 and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998, 55:1449-1455
4. Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S: Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Int Med 1999, 131:363-375
5. Fahey JL, Schnelle JF, Boscardin J, Thomas JK, Gorre ME, Aziz N, Sadeghi H, Nishanian P: Distinct categories of immunologic changes in frail elderly. Mech Ageing Dev 2000, 15:1-20
6. Finkelstein JD: The metabolism of homocysteine: pathways and regulation. Eur J Pediat 1998, 157;S40-S44
7. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H: Neopterin as a marker for activated cell-mediated immunity: Application in HIV infection. Immunol Today 1988, 9:150-215
8. Fuchs D, Weiss G, Reibnegger G, Wachter H: The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious and malignant diseases. Crit Rev Clin Lab Sci 1992, 29:307-341
9. Gerritson T, Vaughn JG, Waisman HA: Identification of homocystine in urine. Biochim Biophys Res Commun 1962, 9:493-496
10. Gottsater A, Anwaar I, Eriksson KF, Mattiasson I, Lindgarde F: Homocysteine is related to neopterin and endothelin-1 in plasma of subjects with disturbed glucose metabolism and reference subjects. Angiology 2000, 51:489-497
11. Graham IM, O'Callaghan P: The role of folic acid in the prevention of cardiovascular disease. Curr Opin Lipidol 2000, 11:577-587
12. Halliwell B: Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? Acta Neurol Scand 1989; 126:S23-S33
13. Joosten E, van den Berg A, Riezler R, Naurath HJ, Lindenbaum J, Stabler SP, Allen RH: Metabolic evidence that deficiencies of vitamin B12 (cobalamin), folate, and vitamin B6 occur commonly in elderly people. Am J Clin Nutr 1993, 58:468-476
14. Leblhuber F, Walli J, Jellinger K, Tilz GP, Widner B, Laccone F, Fuchs D: Activated Immune system in patients with Huntington's disease. Clin Chem Lab Med 1998, 36:747-750
15. Leblhuber F, Walli J, Demel U, Tilz GP, Widner B, Fuchs D: Increased serum neopterin concentrations in patients with Alzheimer's disease. Clin Chem Lab Med 1999, 37:429-431
16. Leblhuber F, Walli J, Artner-Dworzak E, Vrecko K, Widner B, Reibnegger G, Fuchs D: Hyperhomocysteinemia in dementia. J Neural Transm 2000, 107:1469-1474
17. Müller T, Weme B, Fowler B, Kuhn W: Nigral endothelial dysfunction, homocysteine, and Parkinson's disease. Lancet 1999, 354:126-127
18. Murr C, Fuith LC, Widner B, Wirleitner B, Baier-Bitterlich G, Fuchs D: Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Anticancer Res 1999, 19:1721-1728
19. Olszewski AJ, McCully KS: Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radic Biol Med 1993, 14:683-693
20. Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR, Roberts JM: Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998, 179:1605-1611
21. Reibnegger G, Huber LA, Jürgens G, Schoenitzer D, Werner ER, Wachter H, Wick G, Traill KN: Approach to define "normal aging" in man. Immune function, serum lipids, lipoproteins and neopterin levels. Mech Ageing Dev 1989; 46:67-82
22. Sattler W, Leblhuber F, Walli J, Widner B, Fuchs D: Cerebrospinal fluid levels of a-tocopherol and neopterin in patients with dementia. Pteridines 1999, 10:220-224
23. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD, Johnson CL: Serum total homocysteine concentrations in the third national health and nutrition examination survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Int Med 1999, 131:331-339
24. Solichova D, Melichar B, Blaha V, Klejna M, Vavrova J, Palicka V, Zadak Z: Biochemical profile and survival in nonagenarians. Clin Biochem 2001, 34:563-569
25. Turgan N, Habif S, Parildar Z, Ozmen D, Mutaf I, Erdener D, Bayindir O: Association between homocysteine and neopterin in healthy subjects measured by a simple HPLC fluorometric method. Clin Biochem 2001, 34:271-275
26. Ueland PM, Refsum G, Stabler SP, Malinow MR, Andersson A, Allen RH: Total homocysteine in plasma or serum: methods and clinical application. Clin Chem 1993, 39:1964-1979
27. Widner B, Enzinger C, Laich A, Wirleitner B, Fuchs D: Hyperhomocysteinemia pteridines and oxidative stress. Current Drug Metabol 2002, 3:225-232
28. McCaddon A, Regland B, Hudson P, Davies G. Functional vitamin B(12) deficiency and Alzheimer disease. Neurology 2002, 58:1395-1399
29. Widner B, Leblhuber F, Frick B, Laich A, Artner-Dworzak E, Fuchs D. Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease. J Neural Transm 2002; 109:1445-1452
30. Wiesli P, Maly FE, Meniconi A, Czerwenka W, Hoffmann U, Vetter W, Schulthess G: Chlamydia pneumoniae seroposivity and hyperhomocysteinemia are linked in patients with atherosclerosis. Clin Chem 2001, 47:1304-1306